Wound Care Biologics Market set for rapid growth| Top Players: Wright Medical, Osiris Therapeutics, Derma Sciences, Kerecis

The Wound Care Biologics Market is set to exceed USD 2.5 billion By 2025; according to a new research report by Global Market Insights. Rising government initiatives to increase availability of wound care treatment in developed countries will significantly propel the industry growth during the forecast period. Government in developed countries proactively undertake several initiatives such as planning programs to raise the awareness levels amongst the people suffering from burn and other chronic injuries. The government specifically focuses on providing cost-effective quality wound care products that raises its adoption amongst the physicians and doctors. The wound care biologic products are expensive. Therefore, recently government in developing countries such as India have also started focusing on making the wound care treatment affordable that will prove beneficial for the industry growth. However, lack of trained physicians in underdeveloped countries will hamper the wound care biologics market growth up to some extent.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2925

Wound care biologics market | Impact of the rising global geriatric population

Attributing to the advancements in the healthcare sector and the overall improved quality of life, the global populace has been living longer than earlier. This increased life-expectancy has fueled the growth of the geriatric population across the world. In fact, according to statistics by the World Health Organization in 2018, the total population of the world aged 60 years & above is slated to reach 2 billion by 2050, up from the 900 million calculated in a 2015 census. Moreover, the population of people in the 80 years & above age group is projected to reach 434 million by 2050, up from the 125 million calculated in 2015.

The advancements in wound care biologics are one of the most prominent factors behind the exponentially increasing limit of life expectancy. As the geriatric population is easily susceptible to a plethora of chronic infections as well as chronic ailments such as foot ulcers caused by diabetes and other endocrine diseases, the demand for wound care products is expected to increase exponentially. The rise in this demographic is thus expected to prove extremely conducive for wound care biologics market growth.

Wound care biologics market | Impact of the expanding cosmetic surgery industry in APAC

China, owing to the dizzying pace with which its economy obtained growth, is considered one of the world’s biggest consumer group. The nation’s economic growth is such that Chinese consumers are now considered the largest market for a plethora of industrial sectors. One of the sectors that is slated to chronicle its name in this cosmos is plastic surgery. According to a report by Plastic Surgery Practice, the Chinese plastic surgery industry is growing at a rate that is six times quicker than global average in regard to the sheer number of the nation’s population that has undergone a procedure.

Apart from the rising level of income, the market is also being driven by the rising imperative among individuals to have a more aesthetically pleasing face. In 2017 is was expected that more than 14 million individuals across China would undergo a plastic surgeries, a 42% surge from 2016. This factor has been responsible for inducing sizable growth in the nation’s wound care biologics industry. Indeed, China wound care biologics market size is expected to experience a CAGR of more than 11.8% over 2019-2025.

The APAC is also home to South Korea, which has had the world’s highest cosmetic surgery rate per capita. Approximately one in three women in South Korea between 19 & 29 years of age have undergone a procedure. One of the most prominent growth factor behind this thriving industry is that, in South Korea, getting plastic surgery is considered a good career move. Citing a rather trivial instance, even most job applications in the nation often include a photograph of the applicant, indicating that one’s appearance is considered significantly influential in determining whether the applicant is eligible for the job.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2925

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
Eminent industry players operational in wound care biologics market includes Smith & Nephew, Integra Life Sciences, Mölnlycke Health Care AB, Mimedx Group, Wright Medical, Osiris Therapeutics, Derma Sciences, Kerecis, Amnio Technology, Solsys Medica and Skye Biologics. These industry players adopt strategies such as geographic expansions, acquisitions, mergers, and new product launch to sustain market competition. Product approvals from regulatory authorities will also have positive impact on company’s growth. For instance, in November 2013, FDA approved Kerecis’s Omega3, tissue-regeneration technology that is specifically utilized in the treatment of chronic wounds.

Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com

This release was published on openPR.